For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

With a market cap of $90.6 billion, Elevance Health, Inc. (ELV) is a leading health benefits company, providing comprehensive ...

Reports Q4 revenue $201.81M, consensus $192.14M. “We fired on all cylinders throughout 2024, delivering remarkable revenue growth and upgrading ...

In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...

The Madison Investors Fund (class I) decreased 0.4% in the fourth quarter of 2024, compared to the 2.4% increase in the S&P ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

Cigna's strong growth potential, Evernorth expansion, and stock buybacks make it undervalued. Click here to find out why CI ...